Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA 92037, USA.
Science. 2020 Oct 2;370(6512):89-94. doi: 10.1126/science.abd3871. Epub 2020 Aug 4.
Many unknowns exist about human immune responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2-reactive CD4 T cells have been reported in unexposed individuals, suggesting preexisting cross-reactive T cell memory in 20 to 50% of people. However, the source of those T cells has been speculative. Using human blood samples derived before the SARS-CoV-2 virus was discovered in 2019, we mapped 142 T cell epitopes across the SARS-CoV-2 genome to facilitate precise interrogation of the SARS-CoV-2-specific CD4 T cell repertoire. We demonstrate a range of preexisting memory CD4 T cells that are cross-reactive with comparable affinity to SARS-CoV-2 and the common cold coronaviruses human coronavirus (HCoV)-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1. Thus, variegated T cell memory to coronaviruses that cause the common cold may underlie at least some of the extensive heterogeneity observed in coronavirus disease 2019 (COVID-19) disease.
关于人类对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)病毒的免疫反应,存在许多未知因素。有报道称,在未接触过 SARS-CoV-2 的个体中存在 SARS-CoV-2 反应性 CD4 T 细胞,这表明 20%至 50%的人存在预先存在的交叉反应性 T 细胞记忆。然而,这些 T 细胞的来源一直是推测性的。利用在 2019 年发现 SARS-CoV-2 病毒之前采集的人类血液样本,我们在 SARS-CoV-2 基因组上绘制了 142 个 T 细胞表位,以方便对 SARS-CoV-2 特异性 CD4 T 细胞库进行精确检测。我们证明了一系列预先存在的记忆 CD4 T 细胞,它们与 SARS-CoV-2 和普通感冒冠状病毒人冠状病毒(HCoV)-OC43、HCoV-229E、HCoV-NL63 和 HCoV-HKU1 具有相似的亲和力,具有交叉反应性。因此,引起普通感冒的冠状病毒的多样化 T 细胞记忆可能至少是 COVID-19 疾病中观察到的广泛异质性的部分原因。